Skip to main content
Clinical Trials/NCT01346020
NCT01346020
Active, not recruiting
Not Applicable

Genomic Analysis of Patients With Chronic Lymphocytic Leukemia

Universitaire Ziekenhuizen KU Leuven1 site in 1 country53 target enrollmentApril 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Lymphocytic Leukemia
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
53
Locations
1
Primary Endpoint
Time to therapy
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

This study aims to characterize clonal evolution in chronic lymphocytic leukemia (CLL) using different approaches and to identify a possible association with disease progression, i.e. therapy initiation.

  1. Samples This monocentric study is carried out using representative bioarchived leukemic samples with a diagnosis of CLL, either at diagnosis or at evolution. These bioarchived samples were collected locally at our center during years of diagnostic activity, and were accurately pathologically, cytogenetically and molecularly characterized.
  2. Clinical data The clinical data were retrospectively collected through collaboration with the referring physicians.
  3. Methods Samples will be investigated by means of (1) conventional cytogenetics, (2) fluorescence in situ hybridization (FISH) and (3) SNP-arrays. After analysis of the array data sets, significant results will be validated and in addition, results will be correlated with clinical data.
Registry
clinicaltrials.gov
Start Date
April 2010
End Date
November 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • diagnosis of CLL,
  • at least two available stored samples

Exclusion Criteria

  • at least one inclusion criterium not fulfilled

Outcomes

Primary Outcomes

Time to therapy

Time Frame: baseline to day 1 of therapy

Time from diagnosis to the start of first line therapy

Secondary Outcomes

  • Genetic abnormalities detected by karyotyping, FISH or array-analysis(13-102 months)

Study Sites (1)

Loading locations...

Similar Trials